Bio-Techne
TECH
536 hedge funds and large institutions have $10.8B invested in Bio-Techne in 2022 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 212 increasing their positions, 181 reducing their positions, and 56 closing their positions.
311% more call options, than puts
Call options by funds: $20M | Put options by funds: $4.86M
17% more repeat investments, than reductions
Existing positions increased: 212 | Existing positions reduced: 181
8.47% more ownership
Funds ownership: 379.13% → 387.6% (+8.5%)
3% less funds holding
Funds holding: 550 → 536 (-14)
14% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 56
16% less capital invested
Capital invested by funds: $12.9B → $10.8B (-$2.1B)
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$73.3M |
| 2 |
Amundi
Paris,
France
|
+$56.6M |
| 3 |
Select Equity Group
New York
|
+$55.3M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$46.1M |
| 5 |
Renaissance Technologies
New York
|
+$43.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$60.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$35.7M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$29.2M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$28.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$27.2M |
TECH Hedge Fund Activity: Q3 2022 in Review
536 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2022, worth a combined $10.8B — down 16% from $12.9B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of TECH and 48 opened new positions — a net loss of 8 holders — while 181 trimmed existing stakes and 212 added.
The largest buyer was Wellington Management Group, adding an estimated $73.3M. The largest seller was Massachusetts Financial Services, cutting an estimated $60.9M.
- 536 institutional investors held Bio-Techne (TECH) as of Q3 2022, down from 550 in Q2 2022.
- Funds reported $10.8B of Bio-Techne stock for Q3 2022, down 16% quarter-over-quarter.
- 48 funds opened new Bio-Techne positions in Q3 2022 and 56 closed out, a net change of -8 holders.
- The largest Bio-Techne buyer in Q3 2022 was Wellington Management Group, an estimated $73.3M added.
- The largest Bio-Techne seller in Q3 2022 was Massachusetts Financial Services, an estimated $60.9M sold.
Based on aggregated 13F filings for Q3 2022.